CELLCORRECT

Serial Number 78425337
606

Registration Progress

Application Filed
May 26, 2004
Under Examination
Dec 6, 2005
Approved for Publication
Aug 24, 2005
Published for Opposition
Sep 13, 2005
Registered

Trademark Image

CELLCORRECT

Basic Information

Serial Number
78425337
Filing Date
May 26, 2004
Published for Opposition
September 13, 2005
Abandonment Date
June 7, 2006
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 7, 2006
Classes
005

Rights Holder

CeMines, Inc.

03
Address
Suite 100
603 PARK POINT DR
GOLDEN, CO 80401

Ownership History

CeMines, Inc.

Original Applicant
03
Evergreen, CO

CeMines, Inc.

Owner at Publication
03
GOLDEN, CO

Legal Representation

Attorney
Gayle L. Strong

USPTO Deadlines

All Deadlines Cleared

All 4 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

16 events
Date Code Type Description Documents
Aug 7, 2006 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 7, 2006 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Dec 6, 2005 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 30, 2005 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Sep 13, 2005 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 24, 2005 NPUB O NOTICE OF PUBLICATION Loading...
Jul 22, 2005 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jul 15, 2005 ALIE A ASSIGNED TO LIE Loading...
Jul 13, 2005 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 13, 2005 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 6, 2005 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 6, 2005 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 7, 2005 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 7, 2005 CNRT F NON-FINAL ACTION MAILED Loading...
Dec 28, 2004 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 2, 2004 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Genomics, proteomics and regulomics-based research tools, namely, test kits and analysis kits consisting primarily of antibody preparation reagents, and assays for human medical diagnostic and therapy purposes; and genomics, proteomics and regulomics-based diagnostic and therapeutic preparations for clinical and medical research laboratory use
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Pseudo Mark
CELL CORRECT

Classification

International Classes
005